Document is current
Any future updates will be listed below
-
Authors
Beirat, Amir F.
Amarin, Justin Z.
Suradi, Haya H.
Qwaider, Yasmeen Z.
Muhanna, Adel
Maraqa, Bayan
Al-Ani, Abdallah
Al-Hussaini, Maysa
- License Information
-
More Information
Article History
Received: 9 January 2022
Accepted: 16 January 2024
First Online: 28 February 2024
Declarations
:
: The Institutional Review Board (IRB) of King Hussein Cancer Center, which complies with the Declaration of Helsinki and the Good Clinical Practice guidelines, reviewed and approved the study protocol (20KHCC10). The IRB waived the requirement for informed consent because the study involves existing data and no interaction with participants.
: Not applicable.
: The authors declare no competing interests.
